← back to search

Chengru Yang

Harbin Medical University · CN
Area of research
Cancer Research · Surgery
Research interest
Research focused on Cancer research and Pancreatic cancer, with related work in Carcinogenesis, Malignancy, Epigenetics. Notable publications include 'Research progress and applications of epigenetic biomarkers in cancer', 'Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology', and 'Metallothionein 1B attenuates inflammation and hepatic steatosis in MASH by inhibiting the AKT/PI3K pathway'.
h-index
citations
80
works
10
NIH funding
primary concept
email

Recent publications

A Novel 167‐Amino Acid Protein Encoded by CircPCSK6 Inhibits Intrahepatic Cholangiocarcinoma Progression via IKBα Ubiquitination
Advanced Science 2025cited by 7position: middledoi
<scp>PSMD14</scp> Transcriptionally Activated by <scp>MEF2A</scp> Promotes Pancreatic Cancer Development by Upregulating <scp>SPON2</scp> Expression
The Kaohsiung Journal of Medical Sciences 2025cited by 4position: middledoi
Research progress and applications of epigenetic biomarkers in cancer
Frontiers in Pharmacology 2024cited by 19position: middledoi
Interactions between tumor-associated macrophages and regulated cell death: therapeutic implications in immuno-oncology
Frontiers in Oncology 2024cited by 11position: middledoi
Metallothionein 1B attenuates inflammation and hepatic steatosis in MASH by inhibiting the AKT/PI3K pathway
Journal of Lipid Research 2024cited by 9position: middledoi
Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42
Cellular Signalling 2024cited by 7position: middledoi
Polyribonucleotide nucleotidyltransferase 1 participates in metabolic-associated fatty liver disease pathogenesis by affecting lipid metabolism and mitochondrial homeostasis
Molecular Metabolism 2024cited by 7position: middledoi
Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
Frontiers in Bioscience-Landmark 2024cited by 5position: firstdoi
ZNF460-mediated upregulation of APCDD1L-DT promotes cholangiocarcinoma development by inhibiting the ubiquitin-mediated degradation of DVL2
Cancer Gene Therapy 2024cited by 4position: middledoi
Circular RNAs in pancreatic cancer progression
Clinica Chimica Acta 2023cited by 7position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xinlei Zou · University of Electronic Science and Technology of China6 papers (2024–2025)Yifei Ge · Harbin Medical University6 papers (2024–2025)Canghai Guan · Harbin Medical University6 papers (2024–2025)Wujiang Shi · Harbin Medical University5 papers (2024–2025)Zhaoqiang Xu · Harbin Medical University5 papers (2024–2025)Xiangyu Zhong · Tohoku University5 papers (2024–2024)Qingfu Dong · Harbin Medical University4 papers (2023–2024)Xingming Jiang · Harbin Medical University4 papers (2024–2025)Haolin Bao · Harbin Medical University3 papers (2023–2024)Jianjun Gao · Qingdao University3 papers (2024–2024)Xiangyu Zhong · Hebei Medical University3 papers (2024–2025)Shaowu Bi · Harbin Medical University3 papers (2024–2025)Jiehan Li · Hebei Medical University2 papers (2023–2024)Xiangjun Sha · Harbin Medical University2 papers (2024–2024)Sidi Liu · University of Georgia2 papers (2024–2024)Yunhe Hao · Harbin Medical University2 papers (2025–2025)Xinmiao Zhang · Nanchang University2 papers (2024–2024)Jiangang Wang · South China Agricultural University1 papers (2024–2024)Yi Xu · Central South University1 papers (2023–2023)Zixin Liang · Nanjing University of Chinese Medicine1 papers (2023–2023)